Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H-C Kolberg

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Journal of Gynaecological Oncology|January 10, 2006
Characterisation of the promoter region of the human DNA-repair gene Rad51L Hasselbach, S Haase, D Fischer, et al.
European Journal of Gynaecological Oncology|April 1, 2004
Taxanes in the first-line chemotherapy of metastatic breast cancer: reviewM Friedrich, D Diesing, C Villena-Heinsen, et al.
European Journal of Gynaecological Oncology|August 27, 2005
Relationship between chemotherapy with paclitaxel, cisplatin, vinorelbine and titanocene dichloride and expression of proliferation markers and tumour suppressor gene p53 in human ovarian cancer xenografts in nude miceH C Kolberg, C Villena-Heinsen, M M Deml, et al.
Zentralblatt Fur Gynakologie|February 11, 2005
[Treatment results following breast-conserving therapy in primary breast cancer]F Fehlauer, H-D Weinhold, H-C Kolberg, et al.
Geburtshilfe Und Frauenheilkunde|October 18, 2014
Breast Cancer 2012 - New AspectsH-C Kolberg, D Lüftner, M P Lux, et al.
Geburtshilfe Und Frauenheilkunde|March 24, 2015
Breast Cancer Update 2014 - Focus on the Patient and the TumourN Maass, F Schütz, P A Fasching, et al.
Geburtshilfe Und Frauenheilkunde|December 8, 2015
Advances in Breast Cancer - Looking Back over the YearD Lüftner, M P Lux, N Maass, et al.
British Journal of Cancer|June 16, 2005
High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patientsG-B Qiao, Y-L Wu, X-N Yang, et al.
ESMO Open|May 16, 2022
Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task ForceE Razis, M J Escudero, C Palmieri, et al.
Breast (Edinburgh, Scotland)|January 21, 2020
Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patientsC C Hack, L Häberle, S Y Brucker, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Gynaecological Oncology|January 10, 2006
Characterisation of the promoter region of the human DNA-repair gene Rad51L Hasselbach, S Haase, D Fischer, et al.
European Journal of Gynaecological Oncology|April 1, 2004
Taxanes in the first-line chemotherapy of metastatic breast cancer: reviewM Friedrich, D Diesing, C Villena-Heinsen, et al.
European Journal of Gynaecological Oncology|August 27, 2005
Relationship between chemotherapy with paclitaxel, cisplatin, vinorelbine and titanocene dichloride and expression of proliferation markers and tumour suppressor gene p53 in human ovarian cancer xenografts in nude miceH C Kolberg, C Villena-Heinsen, M M Deml, et al.
Zentralblatt Fur Gynakologie|February 11, 2005
[Treatment results following breast-conserving therapy in primary breast cancer]F Fehlauer, H-D Weinhold, H-C Kolberg, et al.
Geburtshilfe Und Frauenheilkunde|October 18, 2014
Breast Cancer 2012 - New AspectsH-C Kolberg, D Lüftner, M P Lux, et al.
Geburtshilfe Und Frauenheilkunde|March 24, 2015
Breast Cancer Update 2014 - Focus on the Patient and the TumourN Maass, F Schütz, P A Fasching, et al.
Geburtshilfe Und Frauenheilkunde|December 8, 2015
Advances in Breast Cancer - Looking Back over the YearD Lüftner, M P Lux, N Maass, et al.
British Journal of Cancer|June 16, 2005
High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patientsG-B Qiao, Y-L Wu, X-N Yang, et al.
ESMO Open|May 16, 2022
Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task ForceE Razis, M J Escudero, C Palmieri, et al.
Breast (Edinburgh, Scotland)|January 21, 2020
Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patientsC C Hack, L Häberle, S Y Brucker, et al.
Pageof 2